Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gait Analysis During Level and Uphill Walking After Lengthening Osteotomy of the Lateral Column (CALCOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03487497
Recruitment Status : Completed
First Posted : April 4, 2018
Last Update Posted : March 2, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

Brief Summary:

A common surgical treatment for posterior tibial tendon dysfunction (and the resulting flat foot) is the correction through a calcaneal lengthening osteotomy of the lateral column (LLC). Clinical studies showed pain relief and functional improvements through different scores. However, according to clinical experience, some patients complain about a limited ankle dorsiflexion after LLC surgery. Several joints of the foot (talocrural, subtalar, talonavicular, calcaneocuboid) contribute to the overall range of motion in foot plantarflexion/dorsiflexion and pronation/supination. Changes in the range of motion in one joint can affect all the other joints. For instance, it was shown that a fusion of the talonavicular joint removes most of the residual hindfoot motion in plantarflexion/dorsiflexion and pronation/supination. Because the lengthening of the lateral column presumably decreases the mobility of the medial column and thus of the talonavicular joint, this surgery can influence the range of motion of the other joints, and hence contribute to the reported decreased ankle dorsiflexion motion.

Patients after LLC have less plantarflexion of the first metatarsal throughout stance of level walking and less inversion of the hindfoot during push-off compared to healthy subjects. Uphill walking requires more ankle plantarflexion and dorsiflexion than level walking. A limitation of the ankle joint mobility especially in dorsiflexion could therefore lead to additional or greater changes in gait patterns (hindfoot and forefoot kinematics) during uphill walking.

The primary objective is:

• To compare differences in hindfoot and forefoot kinematics between level and uphill treadmill walking in relation to passive range of motion

The secondary objectives are:

  • To compare lower leg muscle activation during level and uphill treadmill walking between patients after LLC and healthy subjects
  • To test the association between muscle strength, muscle activation patterns and hindfoot and forefoot kinematics during level and uphill walking and heel rise
  • To relate clinical outcome of LLC surgery by functional scores to passive range of motion

Condition or disease Intervention/treatment
Osteotomy Lengthening; Leg Procedure: Lateral column lengthening osteotomy

Detailed Description:
At the initial assessment, written informed consent will be obtained before participants will undergo a clinical exam (inspection and palpation of the foot, measurement of bilateral passive ankle range of motion). All participants will complete the Short Form (SF)36 and the Foot Function Index20 to obtain pain and functional scores (approximate duration: 30 minutes). Participants will be able to familiarize with treadmill walking at their preferred walking speed. Surface electrodes will be placed bilaterally over the tibialis anterior, gastrocnemius medialis and lateralis, soleus, and peroneus brevis. Isokinetic muscle strength in ankle plantarflexion/ dorsiflexion and inversion/eversion will be tested using the Biodex system 4 Pro (approximate duration: 45 minutes). Reflective surface markers will be placed bilaterally on anatomic landmarks according to the Plug In Gait model and a specific foot model. These markers are seen by 6 Vicon MX cameras. Participants will be asked to stand on the treadmill (h/p cosmos, Zebris), and data for a standing reference trial will be collected. Single-limb heel rise performance with each leg will be tested on the treadmill while kinematic, electromyography (EMG), and pressure data will be measured. Participants will then walk barefoot for 2 minutes at 0% slope while kinematic, EMG, and pressure data will be recorded. Subsequently, the treadmill incline will be increased to 15%, and data for 2 minutes walking at this slope will be recorded followed by three heel rises (approximate duration: 45 minutes). The estimated total time for each participant is 120 minutes.

Layout table for study information
Study Type : Observational
Actual Enrollment : 32 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Gait Analysis During Level and Uphill Walking After Lengthening Osteotomy of the Lateral Column
Actual Study Start Date : November 20, 2017
Actual Primary Completion Date : December 31, 2018
Actual Study Completion Date : December 31, 2018

Group/Cohort Intervention/treatment
Patients
Patients who underwent lateral column lengthening osteotomy
Procedure: Lateral column lengthening osteotomy
Lengthening osteotomy of the lateral column of the foot

Healthy subjects
Healthy subjects without intervention



Primary Outcome Measures :
  1. Passive plantarflexion and dorsiflexion range of motion [ Time Frame: 0 months ]
    measured using a Biodex


Secondary Outcome Measures :
  1. 3D hindfoot and forefoot range of motion during level and uphill walking [ Time Frame: 0 months ]
    assessed as max plantarflexion to max dorsiflexion of the ankle using marker and camera based motion capture

  2. Isokinetic strength in plantarflexion, dorsiflexion, inversion, and eversion [ Time Frame: 0 months ]
    Max moment assessed using a Biodex

  3. Lower leg muscle activation [ Time Frame: 0 months ]
    Max electromyographic signal intensity

  4. Clinical outcome [ Time Frame: 0 months ]
    assessed by American Orthopaedic Foot and Ankle Society (AOFAS) Hindfoot Score (questionnaires) (best score: 100 - no limitations)

  5. Functional outcome [ Time Frame: 0 months ]
    assessed by Foot Function Index (questionnaire) (best score: 0; worst score 100)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
20 patients who had undergone lengthening osteotomy of the lateral column of the foot 2 to 10 years prior and 20 age and sex matched healthy subjects
Criteria

Inclusion Criteria:

  • age > 18 years
  • age < 70 years
  • Patients:
  • Unilateral surgery for posterior tibial tendon dysfunction by flexor digitorum longus transfer and lateral lengthening osteotomy of the calcaneus
  • Minimum of 2 years postoperatively

Exclusion Criteria:

  • Neuromuscular disorders affecting gait
  • Cardiovascular disease
  • Diabetes
  • Pregnancy (if unknown, a pregnancy test (urine test) will be performed)
  • Body mass index > 35 kg/m2
  • Patients:
  • Additional pathologies that influence the mobility of the ankle joint
  • Bilateral surgery
  • Use of walking aids
  • Healthy control group:
  • Lower extremity surgery
  • Pain in the lower extremities within the last 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03487497


Locations
Layout table for location information
Switzerland
University Hospital Basel
Basel, Basel Stadt, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Layout table for investigator information
Principal Investigator: Corina Nüesch, PhD University Hospital, Basel, Switzerland
Layout table for additonal information
Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT03487497    
Other Study ID Numbers: 2015-00254
First Posted: April 4, 2018    Key Record Dates
Last Update Posted: March 2, 2020
Last Verified: February 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Basel, Switzerland:
gait analysis
electromyography
strength test
walking